Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis - Results of an international prospective study

被引:444
作者
Auquier-Dunant, A
Mockenhaupt, M
Naldi, L
Correia, O
Schroder, W
Roujeau, JC
机构
[1] Inst Gustave Roussy, Dept Biostat & Epidemiol, Villejuif, France
[2] Univ Freiburg, Dept Dermatol, Dokumentat Zentrum Schwerer Hautreakt, D-7800 Freiburg, Germany
[3] Univ Milan, Grp Italiano Studi Epidemiol Dermatol, Dept Dermatol, Bergamo, Italy
[4] Hosp Sao Joao, Grp Portugues ELYS, Dept Dermatol & Immunol, Fac Med, Oporto, Portugal
[5] Univ Paris 12, Hop Henri Mondor, Dept Dermatol, F-94010 Creteil, France
关键词
D O I
10.1001/archderm.138.8.1019
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
Background: It was proposed that Stevens-Johnson syndrome and toxic epidermal necrolysis differed from erythema multiforme majus by the pattern and localization of skin lesions. Objective: To evaluate the validity of this clinical separation. Design: Case-control study. Settings: Active survey from 1989 to 1995 of 1800 hospital departments in Europe. Patients: A total of 552 patients and 1720 control subjects. Methods: Cases were sorted into 5 groups (erythema multiforme majus, Stevens-Johnson syndrome, Stevens-Johnson syndrome-toxic epidermal necrolysis overlap, toxic epidermal necrolysis, and unclassified erythema multiforme majus or Stevens-Johnson syndrome) by experts blinded as to exposure to drugs and other factors. Etiologic fractions for herpes and drugs obtained from case-control analyses were compared between these groups. Results: Erythema multiforme majus significantly differed from Stevens-Johnson syndrome, overlap, and toxic epidermal necrolysis by occurrence in younger males, frequent recurrences, less fever, milder mucosal lesions, and lack of association with collagen vascular diseases, human immunodeficiency virus infection, or cancer. Recent or recurrent herpes was the principal risk factor for erythema multiforme majus (etiologic fractions of 29% and 17%, respectively) and had a role in Stevens-Johnson syndrome (etiologic fractions of 6% and 10%) but not in overlap-cases or toxic epidermal necrolysis. Drugs had higher etiologic fractions for Stevens-Johnson syndrome, overlap, or toxic epidermal necrolysis (64%-66%) than for erythema multiforme majus (18%). Unclassified cases mostly behaved clinically like erythema multiforme. Conclusions: This large prospective study confirmed that erythema multiforme majus differs from Stevens-Johnson syndrome and toxic epidermal necrolysis not only in severity but also in several demographic characteristics and causes.
引用
收藏
页码:1019 / 1024
页数:6
相关论文
共 17 条
[1]
ERYTHEMA MULTIFORME WITH MUCOUS-MEMBRANE INVOLVEMENT AND STEVENS-JOHNSON SYNDROME ARE CLINICALLY DIFFERENT DISORDERS WITH DISTINCT CAUSES [J].
ASSIER, H ;
BASTUJIGARIN, S ;
REVUZ, J ;
ROUJEAU, JC .
ARCHIVES OF DERMATOLOGY, 1995, 131 (05) :539-543
[2]
CLINICAL CLASSIFICATION OF CASES OF TOXIC EPIDERMAL NECROLYSIS, STEVENS-JOHNSON SYNDROME, AND ERYTHEMA MULTIFORME [J].
BASTUJIGARIN, S ;
RZANY, B ;
STERN, RS ;
SHEAR, NH ;
NALDI, L ;
ROUJEAU, JC .
ARCHIVES OF DERMATOLOGY, 1993, 129 (01) :92-96
[3]
CLINICOPATHOLOGICAL CORRELATION IN ERYTHEMA MULTIFORME AND STEVENS-JOHNSON SYNDROME [J].
COTE, B ;
WECHSLER, J ;
BASTUJIGARIN, S ;
ASSIER, H ;
REVUZ, J ;
ROUJEAU, JC .
ARCHIVES OF DERMATOLOGY, 1995, 131 (11) :1268-1272
[4]
HEBRA F, 1866, ATLAS HAUTKRANKHEITE, V6, P55
[5]
KAUFMAN DW, 1991, DRUG ETIOLOGY AGRANU, P103
[6]
AN INTERNATIONAL COLLABORATIVE CASE-CONTROL STUDY OF SEVERE CUTANEOUS ADVERSE REACTIONS (SCAR) - DESIGN AND METHODS [J].
KELLY, JP ;
AUQUIER, A ;
RZANY, B ;
NALDI, L ;
BASTUJIGARIN, S ;
CORREIA, O ;
SHAPIRO, S ;
KAUFMAN, DW .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (09) :1099-1108
[7]
Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme:: Interferon-γ is expressed in HAEM lesions and tumor necrosis factor-α in drug-induced erythema multiforme lesions [J].
Kokuba, H ;
Aurelian, L ;
Burnett, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (05) :808-815
[8]
REQUIEM FOR TOXIC EPIDERMAL NECROLYSIS [J].
LYELL, A .
BRITISH JOURNAL OF DERMATOLOGY, 1990, 122 (06) :837-838
[9]
Mockenhaupt M, 1999, J INVEST DERMATOL, V112, P661
[10]
Erythema multiforme and toxic epidermal necrolysis: A comparative study [J].
Paquet, P ;
Pierard, GE .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1997, 19 (02) :127-132